Amarin Corp Plc (AMRN)

[HDGabor]

o-

I was under the believe that when a patient had the last visit, they turned in unused medication and were out of the study. Is this correct?

I was also … however - based on 10-K - it looks like it isn't the case. CTM cost was higher in Q1 2018 than in 2017 ($1.8 million vs $1.0 million).

For the three months ended March 31, 2018 and 2017, we incurred expenses through our CRO in connection with this trial of approximately $6.9 million and $6.7 million, respectively. Inclusive of CTM costs, the combined CRO and CTM costs during the three months ended March 31, 2018 and 2017 for REDUCE-IT were approximately $8.7 million and $7.7 million, respectively. … We expense costs for CTM when allocated to clinical research

Best,
G